Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | DNLI |
---|---|---|
09:32 ET | 14877 | 21.02 |
09:34 ET | 300 | 21 |
09:36 ET | 482 | 21.09 |
09:38 ET | 900 | 20.845 |
09:39 ET | 14000 | 20.97 |
09:41 ET | 800 | 21.07 |
09:43 ET | 1263 | 21.085 |
09:45 ET | 1778 | 21.26 |
09:48 ET | 600 | 21.12 |
09:50 ET | 800 | 21.13 |
09:52 ET | 1066 | 21.095 |
09:54 ET | 400 | 21.08 |
09:56 ET | 1400 | 21.1 |
09:57 ET | 1100 | 21.14 |
09:59 ET | 200 | 21.19 |
10:01 ET | 3613 | 21.15 |
10:03 ET | 400 | 21.09 |
10:06 ET | 1124 | 21.1 |
10:08 ET | 300 | 21.11 |
10:10 ET | 100 | 21.09 |
10:12 ET | 100 | 21.1 |
10:14 ET | 28300 | 21.09 |
10:15 ET | 1100 | 21.125 |
10:17 ET | 1551 | 21.09 |
10:19 ET | 300 | 21.09 |
10:21 ET | 100 | 21.07 |
10:24 ET | 1300 | 21.09 |
10:26 ET | 100 | 21.07 |
10:28 ET | 512 | 21.07 |
10:30 ET | 200 | 21.07 |
10:32 ET | 1281 | 21.0759 |
10:33 ET | 551 | 21.13 |
10:35 ET | 1200 | 21.08 |
10:37 ET | 700 | 21.1 |
10:39 ET | 2444 | 21.145 |
10:42 ET | 100 | 21.14 |
10:44 ET | 300 | 21.16 |
10:46 ET | 555 | 21.13 |
10:48 ET | 100 | 21.13 |
10:50 ET | 400 | 21.19 |
10:51 ET | 1500 | 21.17 |
10:53 ET | 400 | 21.175 |
10:55 ET | 700 | 21.205 |
10:57 ET | 100 | 21.19 |
11:00 ET | 600 | 21.155 |
11:02 ET | 100 | 21.12 |
11:04 ET | 200 | 21.14 |
11:06 ET | 400 | 21.17 |
11:08 ET | 1300 | 21.16 |
11:11 ET | 1300 | 21.185 |
11:13 ET | 300 | 21.22 |
11:15 ET | 2897 | 21.24 |
11:18 ET | 200 | 21.24 |
11:20 ET | 100 | 21.24 |
11:22 ET | 100 | 21.25 |
11:26 ET | 500 | 21.205 |
11:27 ET | 500 | 21.2 |
11:29 ET | 3200 | 21.175 |
11:31 ET | 4177 | 21.16 |
11:33 ET | 1699 | 21.135 |
11:36 ET | 600 | 21.205 |
11:38 ET | 300 | 21.195 |
11:40 ET | 244 | 21.22 |
11:44 ET | 100 | 21.23 |
11:45 ET | 100 | 21.28 |
11:47 ET | 200 | 21.29 |
11:49 ET | 400 | 21.28 |
11:51 ET | 865 | 21.28 |
11:54 ET | 600 | 21.29 |
11:56 ET | 300 | 21.27 |
11:58 ET | 903 | 21.2 |
12:00 ET | 500 | 21.18 |
12:02 ET | 1185 | 21.17 |
12:03 ET | 100 | 21.16 |
12:05 ET | 745 | 21.17 |
12:07 ET | 300 | 21.18 |
12:09 ET | 1087 | 21.17 |
12:12 ET | 405 | 21.2123 |
12:14 ET | 400 | 21.17 |
12:16 ET | 203 | 21.185 |
12:18 ET | 300 | 21.18 |
12:20 ET | 1100 | 21.21 |
12:21 ET | 200 | 21.19 |
12:23 ET | 100 | 21.21 |
12:25 ET | 100 | 21.19 |
12:27 ET | 1700 | 21.16 |
12:30 ET | 300 | 21.195 |
12:32 ET | 784 | 21.16 |
12:34 ET | 500 | 21.16 |
12:36 ET | 927 | 21.175 |
12:38 ET | 200 | 21.17 |
12:39 ET | 350 | 21.16 |
12:41 ET | 1146 | 21.14 |
12:43 ET | 300 | 21.12 |
12:45 ET | 300 | 21.1 |
12:48 ET | 300 | 21.09 |
12:50 ET | 100 | 21.09 |
12:52 ET | 100 | 21.09 |
12:54 ET | 200 | 21.06 |
12:57 ET | 200 | 21.06 |
12:59 ET | 700 | 21.06 |
01:01 ET | 400 | 21.03 |
01:03 ET | 790 | 21.06 |
01:06 ET | 800 | 21.05 |
01:08 ET | 200 | 21.05 |
01:10 ET | 503 | 21.07 |
01:12 ET | 900 | 21.07 |
01:14 ET | 200 | 21.065 |
01:15 ET | 100 | 21.05 |
01:17 ET | 100 | 21.04 |
01:19 ET | 424 | 21.04 |
01:21 ET | 100 | 21.03 |
01:24 ET | 700 | 21.07 |
01:28 ET | 1253 | 21.07 |
01:30 ET | 100 | 21.09 |
01:32 ET | 200 | 21.08 |
01:35 ET | 600 | 21.1 |
01:37 ET | 3772 | 21.095 |
01:39 ET | 318 | 21.09 |
01:42 ET | 637 | 21.09 |
01:44 ET | 1100 | 21.12 |
01:46 ET | 500 | 21.11 |
01:48 ET | 300 | 21.09 |
01:50 ET | 200 | 21.08 |
01:51 ET | 300 | 21.1 |
01:53 ET | 1006 | 21.125 |
01:55 ET | 100 | 21.11 |
01:57 ET | 200 | 21.125 |
02:00 ET | 300 | 21.13 |
02:02 ET | 400 | 21.13 |
02:04 ET | 200 | 21.13 |
02:06 ET | 200 | 21.13 |
02:08 ET | 500 | 21.1 |
02:09 ET | 900 | 21.09 |
02:11 ET | 953 | 21.071 |
02:13 ET | 4558 | 21.01 |
02:15 ET | 200 | 21.01 |
02:18 ET | 300 | 20.99 |
02:20 ET | 3912 | 21.025 |
02:22 ET | 627 | 21.02 |
02:24 ET | 480 | 21.02 |
02:26 ET | 100 | 21.035 |
02:29 ET | 100 | 21.05 |
02:31 ET | 500 | 21.02 |
02:33 ET | 100 | 21.02 |
02:36 ET | 1707 | 21.03 |
02:38 ET | 100 | 21.02 |
02:40 ET | 4908 | 21.05 |
02:42 ET | 1284 | 21.065 |
02:44 ET | 200 | 21.08 |
02:45 ET | 600 | 21.06 |
02:47 ET | 300 | 21.06 |
02:49 ET | 700 | 21.03 |
02:51 ET | 200 | 21.07 |
02:56 ET | 200 | 21.07 |
02:58 ET | 200 | 21.07 |
03:00 ET | 700 | 21.07 |
03:02 ET | 400 | 21.06 |
03:03 ET | 100 | 21.07 |
03:05 ET | 250 | 21.1097 |
03:07 ET | 1300 | 21.16 |
03:09 ET | 1611 | 21.23 |
03:12 ET | 1333 | 21.22 |
03:14 ET | 1911 | 21.18 |
03:16 ET | 200 | 21.2 |
03:18 ET | 4126 | 21.131 |
03:20 ET | 300 | 21.13 |
03:21 ET | 100 | 21.145 |
03:23 ET | 400 | 21.16 |
03:25 ET | 300 | 21.165 |
03:27 ET | 880 | 21.14 |
03:30 ET | 200 | 21.14 |
03:32 ET | 400 | 21.17 |
03:34 ET | 1866 | 21.16 |
03:36 ET | 1500 | 21.16 |
03:38 ET | 1000 | 21.18 |
03:39 ET | 900 | 21.185 |
03:41 ET | 1187 | 21.21 |
03:43 ET | 700 | 21.21 |
03:45 ET | 1818 | 21.2 |
03:48 ET | 600 | 21.19 |
03:50 ET | 1138 | 21.215 |
03:52 ET | 3029 | 21.21 |
03:54 ET | 1941 | 21.185 |
03:56 ET | 4737 | 21.18 |
03:57 ET | 3911 | 21.15 |
03:59 ET | 122769 | 21.14 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Denali Therapeutics Inc | 3.0B | -21.9x | --- |
MorphoSys AG | 2.8B | -5.5x | --- |
Amicus Therapeutics Inc | 3.0B | -20.3x | --- |
Arrowhead Pharmaceuticals Inc | 3.2B | -6.0x | --- |
Genmab A/S | 16.8B | 21.2x | +22.71% |
TG Therapeutics Inc | 2.9B | 86.2x | --- |
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0B |
---|---|
Revenue (TTM) | $295.4M |
Shares Outstanding | 142.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.39 |
EPS | $-0.97 |
Book Value | $7.45 |
P/E Ratio | -21.9x |
Price/Sales (TTM) | 10.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -65.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.